Karachi: Liven Pharma Limited has issued a correction and clarification regarding its Annual Report for the year ended June 30, 2026, following the identification of typographical and clerical errors. The pharmaceutical company, adhering to Section 96 of the Securities Act, 2015, and Clause 5.6.1 (a) of the PSX Regulations, addressed these discrepancies in a communication to the Pakistan Stock Exchange Limited and its shareholders.

The company highlighted two specific errors in its report. Firstly, the Statement of Compliance incorrectly referenced the year "2025," which should be "2026." Secondly, in the Notice of General Meeting, the term "Six Months" was mistakenly used instead of the correct term "Annual." Liven Pharma assured stakeholders that these were purely inadvertent errors and do not affect the financial statements, auditor's report, directors' report, or any other substantive information within the documents.

According to information available from the Pakistan Stock Exchange (PSX), Liven Pharma Limited has promptly corrected these errors to ensure transparency and accurate disclosure. The company has requested all stakeholders to consider the corrections while reviewing the Annual Report and the Notice of the Annual General Meeting.

This clarification from Liven Pharma underscores its commitment to maintaining transparency with its shareholders and the financial community, a move aligned with the regulatory framework governing listed companies in Pakistan.